Full-Time
Posted on 8/16/2024
Develops microbiome-based therapies using bacteria
Senior, Expert
Cambridge, MA, USA
Vedanta Biosciences focuses on developing microbiome therapies using groups of beneficial bacteria known as bacterial consortia. These consortia can colonize the human intestine and have the potential to treat various diseases. The company utilizes a proprietary discovery platform to identify and assemble these bacteria into effective therapeutic teams. Unlike many competitors, Vedanta has achieved commercial-scale production of its drug candidates while adhering to strict FDA regulations for safety and quality. The goal of Vedanta Biosciences is to transform disease treatment by providing new options for patients through its innovative approach to drug discovery.
Company Stage
Late Stage VC
Total Funding
$364.5M
Headquarters
Cambridge, Massachusetts
Founded
2010
Help us improve and share your feedback! Did you find this helpful?